NCT00714857View on ClinicalTrials.gov

Population Pharmacokinetics of Dexmedetomidine in ICU Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Pharmacokinetics
Interventions
DRUG

Dexmedetomidine

The patients are given a normal loading dose (10 min infusion at a rate of 3-6 μg/kg/h) of dexmedetomidine followed by continuous infusion of 0.1 - 2.5 μg/kg/h for the period of time the responsible physician finds reasonable.

Trial Locations (1)

FIN-20521

Turku University Hospital, Turku

All Listed Sponsors
lead

University of Turku

OTHER

NCT00714857 - Population Pharmacokinetics of Dexmedetomidine in ICU Patients | Biotech Hunter | Biotech Hunter